Indeed, it has already been demonstrated that 2-AG may modulate the production of type 1 IFN in pDCs from SLE patients [26], but no information was as yet available about its potential effect on type 2 IFN (namely IFN-ɣ). Here, IFNA1 is linked to systemic lupus erythematosus.